MA S724

Requires health insurance carriers and pharmacy benefit managers to pass through at least 80% of estimated prescription drug rebates to patients at the point of sale, reducing out-of-pocket cost-sharing amounts

Mandates annual compliance reports from carriers to the Division of Insurance by April 1, with fines up to $5,000 per day for noncompliance

Protects rebate information as confidential trade secrets, prohibiting pharmacy benefit managers from disclosing specific rebate amounts by product, manufacturer, or pharmacy

Directs the Health Policy Commission and Executive Office of Health and Human Services to study cell and gene therapy access for MassHealth patients and vulnerable populations, covering the forecast period 2027-2037

Requires the cell and gene therapy report to assess reimbursement barriers, health equity impacts on racial/ethnic minorities, and healthcare facility infrastructure adequacy, with findings due by July 30, 2028